title: Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
authors.forename: A
authors.initials: A
authors.lastname: Pileri
authors.forename: T
authors.initials: T
authors.lastname: Barbui
authors.forename: M
authors.initials: M
authors.lastname: Boccadoro
authors.forename: B
authors.initials: B
authors.lastname: Comotti
authors.forename: F
authors.initials: F
authors.lastname: Dammacco
authors.forename: A
authors.initials: A
authors.lastname: Gallamini
authors.forename: F
authors.initials: F
authors.lastname: Marmont
authors.forename: G
authors.initials: G
authors.lastname: Neretto
authors.forename: M T
authors.initials: MT
authors.lastname: Petrucci
authors.forename: L
authors.initials: L
authors.lastname: Resegotti
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D002330:Carmustine / Q000008:administration & dosage; D002453:Cell Cycle; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D010265:Paraproteinemias / Q000175:diagnosis; D010950:Plasma Cells / Q000473:pathology*; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D011897:Random Allocation; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone